SENATE DOCKET, NO. 86        FILED ON: 1/10/2023

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1271

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Bruce E. Tarr

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to fetal opioid drug exposure.

_______________

PETITION OF:

 

Name:

District/Address:

Bruce E. Tarr

First Essex and Middlesex


SENATE DOCKET, NO. 86        FILED ON: 1/10/2023

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1271

By Mr. Tarr, a petition (accompanied by bill, Senate, No. 1271) of Bruce E. Tarr for legislation relative to fetal opioid drug exposure.  Mental Health, Substance Use and Recovery.

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 2297 OF 2019-2020.]

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Third General Court
(2023-2024)

_______________

 

An Act relative to fetal opioid drug exposure.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Notwithstanding any general or special law to the contrary the commissioner of the department of developmental services shall include fetal opiod drug exposure and addiction under the definition of Closely Related Developmental Conditions as defined under 115 CMR  2 and 115 CMR 6.06(1).

SECTION 2. The commissioner of the department of development services shall at their discretion include additional diagnosis as part of the definition of closely related developmental condition.